Table 1 Clinicalpathologic characteristics of cohort
From: The prognostic value of routine preoperative blood parameters in muscle-invasive bladder cancer
Factors | NLR | PLR | HGB | ||||||
|---|---|---|---|---|---|---|---|---|---|
NLR ≥ 2.42 (n = 103) | NLR < 2.42 (n = 99) | P | PLR ≥ 112 (n = 102) | PLR < 112 (n = 100) | P | HGB ≥ 125 (n = 108) | HGB < 125 (n = 94) | P | |
Age(x ± s) /years | 66.1 ± 9.2 | 63.8 ± 10.2 | 0.094 | 65.4 ± 9.5 | 64.6 ± 10.0 | 0.574 | 63.7 ± 9.7 | 66.4 ± 9.7 | 0.050 |
BMI(x ± s) /kg.m−2 | 22.7 ± 3.4 | 23.1 ± 2.9 | 0.356 | 22.7 ± 3.5 | 23.1 ± 2.8 | 0.290 | 23.3 ± 3.1 | 22.5 ± 3.2 | 0.082 |
Gender [n(%)] | 0.002* | 0.660 | 0.001* | ||||||
Male | 94 (91.3) | 74 (74.7) | 86 (84.3) | 82 (82.0) | 99 (91.7) | 69 (73.4) | |||
Female | 9 (8.7) | 25 (25.3) | 16 (15.7) | 18 (18.0) | 9 (8.3) | 25 (26.6) | |||
Smoking [n(%)] | 0.411 | 0.329 | 0.535 | ||||||
yes | 59 (57.3) | 51 (51.5) | 59 (57.8) | 51 (51.0) | 61 (56.5) | 49 (52.1) | |||
no | 44 (42.7) | 48 (48.5) | 43 (42.2) | 49 (49.0) | 47 (43.5) | 45 (47.9) | |||
Pathological grade [n(%)] | 0.006* | 0.195 | 0.747 | ||||||
Low grade | 13 (12.6) | 28 (28.3) | 17 (16.7) | 24 (24.0) | 21 (19.4) | 20 (21.3) | |||
High grade | 90 (87.4) | 71 (71.7) | 85 (83.3) | 76 (76.0) | 87 (80.6) | 74 (78.7) | |||
Pathological T stage [n(%)] | 0.006* | 0.012* | 0.044* | ||||||
T2 | 61 (59.2) | 79 (79.8) | 61 (59.8) | 79 (79.0) | 83 (76.9) | 57 (60.6) | |||
T3 | 22 (21.4) | 11 (11.1) | 21 (20.6) | 12 (12.0) | 13 (12.0) | 20 (21.3) | |||
T4 | 20 (19.4) | 9 (9.1) | 20 (19.6) | 9 (9.0) | 12 (11.1) | 17 (18.1) | |||
Lymph node [n(%)] | 0.022* | 0.216 | 0.012* | ||||||
Positive | 24 (23.3) | 11 (11.1) | 21 (20.6) | 14 (14.0) | 12 (11.1) | 23 (24.5) | |||
Negative | 79 (76.7) | 88 (88.9) | 81 (79.4) | 86 (86.0) | 96 (88.9) | 71 (75.5) | |||